This invention relates to pyrrolocarbazole derivatives according formula I wherein R.sup.1, R.sup.2, R.sup.7, R.sup.8, R.sup.9, X and Y are as defined in the specification wherein said derivatives specifically inhibit one or both of the checkpoint kinases Wee1 and Chk1 ##STR00001##